Edition:
India

People: Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

1.46USD
15 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.46
Open
$1.41
Day's High
$1.54
Day's Low
$1.40
Volume
164,318
Avg. Vol
63,537
52-wk High
$4.25
52-wk Low
$1.20

Moll, Thomas 

Dr. Thomas Moll, Ph.D., is Vice President - Research of Adamis Pharmaceuticals Corporation. Dr. Moll joined Adamis Pharmaceuticals in February 2008 as Vice President of Research. He has more than 20 years of experience in both academic and industrial preclinical research and development in the areas of inflammation, immunology and cancer biology. Prior to joining Adamis, Dr. Moll was Vice President of Research at privately held Telos Pharmaceuticals from 2003 to 2008. From 1998 to 2003 he was Vice President of Immunology at Cardion AG, a privately held German biotech company. Dr. Moll holds a diploma in Biology II from the University of Basel, Switzerland, and received his doctorate degree in Genetics and Biochemistry from the University of Vienna, Austria.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Williams

540,000

Dennis Carlo

2,562,760

Robert Hopkins

1,307,310

David Marguglio

1,456,640

Karen Daniels

259,891

Thomas Moll

--
As Of  31 Dec 2017